ERYP Market Cap History



Below is a table of the ERYP market cap history going back to 7/26/2019:

Date ERYP Market Cap
7/26/2019702.00M

Also see: ERYP Shares Outstanding History
and ERYP YTD Return
Mouse over chart for data details
7/26/2019
Erytech Pharma is a biopharmaceutical company developing therapies for various forms of cancer and orphan diseases. Utilizing its proprietary ERYCAPS platform, which uses a technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, Co. is developing a pipeline of product candidates for patients with unmet medical needs. Co.'s main product candidate, eryaspase, targets the metabolism of cancer cells by depriving the cells of asparagine, an amino acid necessary for their survival and critical in maintaining the cells' rapid growth rate. Co. is developing eryaspase for the treatment of cancer, including pancreatic cancer and triple negative breast cancer. We show 1 historical shares outstanding datapoints in our ERYP shares outstanding history coverage, used to compute ERYP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ERYP market cap history over the course of time is important for investors interested in comparing ERYP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ERYP versus a peer is one thing; comparing ERYP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ERYP can fluctuate over the course of history. With this page we aim to empower investors researching ERYP by allowing them to research the ERYP market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ERYP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Erytech Pharma SA (ERYP) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ESAC Market Cap History
ESGU Market Cap History
ESHA Market Cap History
ESM Market Cap History
ESML Market Cap History
ESNT Market Cap History
ESPO Market Cap History
ESSC Market Cap History
ESTA Market Cap History
ESTC Market Cap History
More Miscellaneous companies »

 

ERYP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.